Mark Cuban is game to chat on social media—just not necessarily on X, formerly Twitter, he told the Fortune Brainstorm ...

Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

"There's nobody who looks at the healthcare system or the pharmaceutical industry and says ‘wow, that’s well run.'" ...

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are taking ...

Considering that he's worth an estimated $5.7 billion, entrepreneur and investor Mark Cuban probably doesn't have a lot of ...

Mark Cuban took a time out and explained his journey from $1 million to $1 billion during an interview with GQ Sports in the year 2022. He elaborated that investing wisely was the key, and he has been ...

About Mark Cuban's Cost Plus Drug Company The Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs) aims to fundamentally change the way the pharmaceutical industry operates.